HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics | Zendy

Ljubomir Ognjenovic | Zendy; Ѓорѓи Трајковски | Zendy; Stojan Gjoshev | Zendy; Aleksandar Shumkovski | Zendy; Darko Dzambaz | Zendy; Dragan Hadzi-Manchev | Zendy; Goce Volcevski | Zendy; Igor Fildishevski | Zendy; Dafiikolova | Zendy; Gordana Petrushevska | Zendy; Vesna Janevska | Zendy; Vlado Janevski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics

Author(s) -

Ljubomir Ognjenovic,

Ѓорѓи Трајковски,

Stojan Gjoshev,

Aleksandar Shumkovski,

Darko Dzambaz,

Dragan Hadzi-Manchev,

Goce Volcevski,

Igor Fildishevski,

Dafiikolova,

Gordana Petrushevska,

Vesna Janevska,

Vlado Janevski

Publication year - 2018

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2018.280

Subject(s) - medicine , trastuzumab , stage (stratigraphy) , pathological , gastric carcinoma , lymph , oncology , immunohistochemistry , carcinoma , disease , pathology , clinical significance , cancer , breast cancer , paleontology , biology

HER2 protein expression in gastric carcinoma, in correlation with existing, acknowledged prognostic factors which include the parameters that determine the TNM stage of the disease, could become the basis for ongoing research in the field of molecular targeted and personalised therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research